Aerovate Therapeutics Inc...
(AVTE)
undefined
undefined%
At close: undefined
2.70
0.19%
After-hours Jan 06, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 23.49M | 22.40M | 54.20M | 4.57M | 3.51M |
| Short-Term Investments | 98.95M | 106.82M | 113.18M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 2.28M | 2.56M | 302.00K | n/a | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.79M | 2.28M | 6.96M | 103.00K | n/a |
| Total Current Assets | 124.23M | 131.50M | 174.33M | 4.68M | 3.51M |
| Property-Plant & Equipment | 902.00K | 1.25M | 728.00K | 39.00K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.19M | 3.81M | 1.03M | 39.00K | n/a |
| Total Assets | 127.42M | 135.30M | 175.36M | 4.71M | 3.51M |
| Account Payables | 2.40M | 2.58M | 1.21M | 612.00K | 542.00K |
| Deferred Revenue | n/a | n/a | 1.01M | n/a | n/a |
| Short-Term Debt | 420.00K | 770.00K | 384.00K | n/a | n/a |
| Other Current Liabilities | 14.82M | 4.44M | 958.00K | 1.16M | 115.00K |
| Total Current Liabilities | 17.64M | 7.78M | 2.55M | 1.77M | 657.00K |
| Long-Term Debt | 255.00K | 705.00K | 382.00K | n/a | 2.50M |
| Other Long-Term Liabilities | 70.00K | 71.00K | 13.00K | n/a | 4.00M |
| Total Long-Term Liabilities | 325.00K | 776.00K | 395.00K | 16.29M | 6.50M |
| Total Liabilities | 17.96M | 8.56M | 2.94M | 18.06M | 7.16M |
| Total Debt | 675.00K | 1.09M | 574.00K | n/a | 2.50M |
| Common Stock | 3.00K | 2.00K | 2.00K | n/a | n/a |
| Retained Earnings | -163.42M | -87.90M | -36.39M | -13.41M | -3.64M |
| Comprehensive Income | 237.00K | -466.00K | -59.00K | n/a | n/a |
| Shareholders Equity | 109.46M | 126.74M | 172.42M | -13.34M | -3.64M |
| Total Investments | 98.95M | 106.82M | 113.18M | n/a | n/a |